Krebs Biochemicals & Industries Ltd (KREBSBIO) — Voting Results | 29 September 2026

29 September 2026 · BSE 🟡 Notable Neutral

By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings

📢 Key Event

All five AGM resolutions passed with requisite majority

🔄 What Changed

None

💡 Investor Takeaway

Routine procedural filing with no direct impact on shareholders.

Krebs Biochemicals & Industries Limited announced voting results from its September 29, 2026 AGM, confirming all five proposed resolutions passed with requisite majority. The remote e-voting period ran from September 25 to 28, 2026, with 47 ballots cast remotely and 11 at the virtual meeting. Consolidated results show near-unanimous approval across items including financial statements, director appointments, related party transactions with IPCA Laboratories, and auditor remuneration. Scrutinizer Kritika Sharma verified compliance with e-voting procedures under SEBI and Companies Act regulations.

📄 View Original Announcement (PDF)

📊 Stock Analysis — KREBSBIO ✨ Ask AI About This

About Krebs Biochemicals & Industries Ltd (KREBSBIO)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹121.84 CrROE: 8.7%ROCE: -10.9%

View full KREBSBIO stock details →

📡 Get AI alerts when KREBSBIO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track KREBSBIO — Free

💡 Ask AI about this filing

"What was the exact vote count for item 4 related party transaction?""How many shareholders participated in remote e-voting versus in-meeting voting?""What is the company's policy on director re-appointment rotation limits?"

Ask AI Free →

📊 More KREBSBIO filings

Announcement — 21 September 2026Krebs Biochemicals & Industries Ltd announced that its trading window will close on September 30, 20...
🟡 Board Meeting — 4 September 2026Krebs Biochemicals & Industries Limited announced its 34th Annual General Meeting (AGM) to be held o...
🔴 Annual Report — 4 September 2026Krebs Biochemicals & Industries Limited reported a consolidated net loss of ₹1,693.31 Lakhs for FY 2...
🟡 Board Meeting — 6 August 2026The board approved unaudited Q1 FY26 results and a limited auditor review, confirming financials for...
share transfer — 2 July 2026Krebs Biochemicals & Industries Limited received SEBI-mandated certificates from its share transfer ...

See all KREBSBIO filings →

🔥 Also filed on 29 September 2026

ADANIPOWERAdani Power LtdAnnouncement APOLLOApollo Micro Systems LtdAnnouncement ADANIENTAdani Enterprises LtdAnnouncement ADANIPORTSAdani Ports & Special Economic Zone LtdAnnouncement PFOCUSPrime Focus LtdAnnouncement MCXMulti Commodity Exchange of India LtdAnnouncement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when KREBSBIO files new disclosures

Track KREBSBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.